Xcelience, LLC We are a premier provider of formulation development and manufacturing solutions with a solid track record for accelerating early phase small molecule development. Our outstanding quality record, significant pharmaceutical development expertise, willingness to customize, and disciplined project management enable us to deliver a real advantage to clients with the need to speed potential drugs to clinical trials. Since 1997, the company has been renowned for reliably expediting drug development for solid, semi-solid, and oral liquid dosage forms. Our formulation development scientists have considerable experience overcoming challenges associated with physical and chemical properties of drug substance, or limited quantities of active pharmaceutical ingredient (API), in a manner that results in compounds with improved solubility and bioavailability. Our company operates out of a cGMP compliant, FDA audited, DEA licensed facility in Tampa, Florida. We are more than just the market leader for powder-in-capsule services, which enable clients to fill very small amounts of API into capsule and reduce time to First-in-Human studies by as much as 45% relative to traditional drug development programs, we are a full spectrum formulation development and pharmaceutical manufacturing provider. Partnering with a specialist like us for drug preformulation and early phase development can reduce product risk and accelerate drug development timelines.